Navigation Links
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD, PhD, Implement Exempted Informational Materials Exchange
Date:11/5/2013

Philadelphia, PA (PRWEB) November 05, 2013

Bioquark, Inc., (http://www.bioquark.com) a company focused on the development of combinatorial biologics for regeneration and disease reversion in human organs and tissues, has implemented an exempted informational materials exchange with Dr. Calixto Machado, MD, PhD, President of the International Symposium on Brain Death and Disorders of Consciousness, President of the Cuban Society of Neurophysiology, and Senior Professor and Researcher at the Institute of Neurology and Neurosurgery, Havana, Cuba. This exchange is consistent with the Berman Amendment in the Ominbus Trade and Competitiveness Act of 1988 (amending the International Emergency Economic Powers Act and the TWEA) and with the Cuban Assets Control Regulations. It will not involve the exportation of technical data to Cuba or any Cuban national and therefore is consistent with the Export Administration Act and the Export Administration Regulations.

“We are honored to be exchanging information with the world’s leading expert in the areas of brain death, coma, and vegetative states,” said Ira S. Pastor, CEO, Bioquark Inc. “We look forward to evaluating Dr. Machado’s extensive existing information portfolio in the treatment of patients with disorders of consciousness as Bioquark Inc. further develops its programs specificaly focused on CNS regeneration and repair.”

Recently granted a 5-year visa to travel throughout the U.S., Dr. Machado has spent over 20 years devoted to the topic of brain death and altered consciousness, authoring dozens of scientific papers and books, including Brain Death: A Reappraisal.

“I have long studied the topic of death and brain death because of my love of life and human beings. I look forward to exchanging permitted information with Bioquark Inc. as it develops as a clinical company focusing on regeneration and repair of the human brain,” said Dr. Machado.

Brain death is the legal definition of human death in most countries around the world. However, while humans lack substantial regenerative capabilities in the CNS, many non-human species can repair, regenerate and remodel substantial portions of their brains even after critical life-threatening trauma.

“We are at a very unique moment in history where the convergence of the tools of biotechnology, resuscitation / reanimation research, and clinical neuroscience have placed us on the verge of major scientific breakthroughs,” says Sergei Paylian, Founder, Chief Science Officer, and President of Bioquark Inc.

About Bioquark, Inc.

Bioquark Inc. is focused on the development of biologic based products that have the ability to alter the regulatory state of human tissues and organs, with the goal of curing a wide range of diseases, as well as effecting complex regeneration.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11298629.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Narconon International Introduces Its Life-Saving Addiction Recovery Technology to Galapagos Islands
2. Mercola.Com Revamps International Shipping for Improved Customer Service
3. Synthetic Turf International Partners with Amazing Pet Expo
4. Medical Ministry International Joins the National #GivingTuesday Movement to Encourage Spending with a Purpose
5. People hold on to their crises or traumas for far too long, says internationally recognised hypnotherapist, author and speaker Dr Tracie O’Keefe DCH
6. CME Course to Feature International Experts on Mesothelioma
7. International Essential Tremor Foundation to Facilitate Essential Tremor Seminar in Los Angeles,Calif.
8. Joint IOF-ISCD meeting in Orlando to draw international delegates
9. International group finds 11 new Alzheimers genes to target for drug discovery
10. Merrill DataSite Releases New Comments: Major Uptick in International Acquisitions by US Firms, Report Finds
11. Narconon International Presents to the 14th Latin American Congress of Clinical Toxicology and Chemical Safety
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 06, 2016 , ... For many years, Andrew G. Zubinas has ... The beauty of the Lithuanian language and its poetry inspired him in ... Zubinas lyrically explores all aspects of a living, breathing forest where nothing ever stays ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
(Date:12/5/2016)... Reading, PA (PRWEB) , ... December 05, 2016 , ... ... partner in the United States and Canada for distribution of their natural fruits ... Hansen colors line is an exciting addition to our Life Sciences product portfolio,” ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Partners ("GPP") portfolio company, today announced it has acquired the assets of ... was previously a subsidiary of Chiltern International and focuses on clinical trial ...
(Date:12/5/2016)... (PRWEB) , ... December 05, 2016 , ... The new ... the individual looking to buy neoprene knee sleeves for lifting and any ... design focuses heavily on two main aspects to provide a higher quality knee sleeve ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Eisai Inc. announced today new analyses and ... of the American Epilepsy Society (AES). ... adjunctive therapy for the treatment of partial onset seizures ... generalized tonic-clonic seizures (PGTC) in patients with epilepsy who ... Important Safety Information for FYCOMPA, including Boxed WARNING for ...
(Date:12/5/2016)... , Dec 5, 2016 Research and ... and Pregnancy Rapid Test Market Size, Share, Development, Growth and Demand ... ... The global female fertility and pregnancy rapid test market is ... global Female fertility and pregnancy rapid test market is witnessing high ...
(Date:12/5/2016)... AVIV, Israel , December 5, 2016 ... to identifying, in-licensing and developing promising therapeutic candidates, presents positive ... for BL-8040, the Company,s leading oncology platform at the ongoing ... in San Diego, California . ... , , ...
Breaking Medicine Technology: